Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
30-Sep-2026 | 828.2 | 828.2 | 811.1 | 818.5 | 15,646 | 16,11,42,528.75 | 1,03,927 |
01-Oct-2026 | 815 | 828.2 | 802.2 | 813.1 | 15,063 | 15,60,82,032.1 | 85,851 |
05-Oct-2026 | 819 | 825 | 796.35 | 801.35 | 9,967 | 9,44,53,573.8 | 52,310 |
06-Oct-2026 | 802 | 818 | 796.3 | 814.65 | 8,106 | 10,41,21,110.45 | 71,715 |
07-Oct-2026 | 819.8 | 833 | 814.65 | 822.55 | 11,753 | 12,69,20,148.4 | 69,263 |
08-Oct-2026 | 816.6 | 831.95 | 773.2 | 786.7 | 28,526 | 23,91,79,908.05 | 1,36,010 |
09-Oct-2026 | 780.8 | 791.9 | 740.8 | 751.85 | 33,985 | 33,33,75,715.25 | 1,94,814 |
12-Oct-2026 | 750 | 774.65 | 749.3 | 751.45 | 27,985 | 13,39,13,901.85 | 97,721 |
13-Oct-2026 | 746.1 | 774.55 | 735 | 769.3 | 14,209 | 10,08,58,661.05 | 64,443 |
14-Oct-2026 | 773.95 | 776 | 753.3 | 769.95 | 13,445 | 10,25,90,079.3 | 67,620 |
15-Oct-2026 | 769.95 | 769.95 | 743.2 | 749.8 | 17,129 | 9,36,13,390.2 | 69,318 |
16-Oct-2026 | 749.8 | 752.8 | 728.7 | 731.45 | 13,615 | 11,09,40,953.1 | 78,018 |
19-Oct-2026 | 731.45 | 739.4 | 704.5 | 709.55 | 27,557 | 35,50,05,453.9 | 3,03,334 |
21-Oct-2026 | 708 | 719.35 | 685 | 694.05 | 26,552 | 28,77,63,860.1 | 2,53,345 |
22-Oct-2026 | 680.1 | 695.25 | 675 | 680.2 | 21,090 | 20,73,31,006.85 | 1,52,877 |
23-Oct-2026 | 676 | 679.45 | 663 | 669 | 15,123 | 12,69,64,763.7 | 98,952 |
26-Oct-2026 | 665 | 688.55 | 658 | 686.6 | 13,516 | 10,14,96,144.3 | 72,322 |
27-Oct-2026 | 676 | 724.9 | 676 | 719.25 | 13,150 | 10,11,64,556.8 | 62,120 |
28-Oct-2026 | 715 | 733 | 709.25 | 722.7 | 7,286 | 5,61,69,128.9 | 33,739 |
29-Oct-2026 | 717.6 | 745 | 714.85 | 741.05 | 11,192 | 8,10,31,917.35 | 62,815 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
